Evacarb 125mcg Injection
Marketer
Celon Laboratories Ltd
Salt Composition
Carboprost (125mcg)
Overview Evacarb 125mcg Injection
Postpartum uterine hemorrhage is managed with Evacarb 125mcg Injection, a medication that promotes uterine muscle contraction to staunch excessive bleeding. Administered intramuscularly by a physician in a hospital setting only, self-injection is strictly prohibited. Common side effects include nausea, facial flushing, cephalalgia, and rigors. Report any concerning symptoms to your doctor; management strategies may be available. Dizziness necessitates avoidance of driving and activities requiring concentration. Prior to treatment, disclose any history of cardiac disease, hypertension, hypotension, hepatic or renal impairment, and a complete list of current medications, as interactions may compromise Evacarb's efficacy or alter its effects. Crucially, this medication is exclusively for postpartum use; it is contraindicated during pregnancy.
Primary Ingredients of Evacarb 125mcg Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Evacarb 125mcg Injection
Hemorrhage postpartum
Major Benefits of Evacarb 125mcg Injection:
This medication will be administered by your physician or registered nurse; please refrain from self-medication.
Common Side effects of Evacarb 125mcg Injection:
- Nausea
- Vomiting
- Headache
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hot flashes
- Diarrhea
- Chills
- Placental retention
- Cough
How to use Evacarb 125mcg Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Evacarb 125mcg Injection works:
Uterine muscle contraction is induced by Evacarb 125mcg Injection, thereby managing postpartum hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Evacarb 125mcg Injection may pose safety risks; seek medical advice before combining them.
PregnancyUNSAFE
Administering Evacarb 125mcg Injection to pregnant individuals poses a substantial risk. Pregnant women should consult their physician, as research in animal models and human studies indicates considerable harm to the fetus.
Breast feedingCAUTION
The administration of Evacarb 125mcg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Evacarb 125mcg Injection might induce adverse reactions impacting driving capabilities. Potential side effects, such as dizziness, drowsiness, or loss of consciousness, could impair driving skills.
KidneyCAUTION
Patients with impaired kidney function should use Evacarb 125mcg Injection cautiously, potentially requiring a modified dosage. Physician consultation is advised. Evacarb 125mcg Injection is contraindicated in individuals experiencing active kidney disease.
LiverCAUTION
Patients with liver impairment should use Evacarb 125mcg Injection cautiously, potentially requiring dosage modification. A physician's consultation is advised. Evacarb 125mcg Injection is contraindicated in individuals experiencing active liver disease.
What if you forget to take Evacarb 125mcg Injection :
NA
Facts to Know About Evacarb 125mcg Injection
| Label | Value |
|---|---|
| Chemical Category | Prostaglandin Analog |
| Developing Habits | No. |
| Treatment Category | Obstetrics and Gynecology |
3,018 People bought this recently